• Hepatic Perfusion Disorder Associated with Focal Liver Lesions: Contrast-enhanced US Patterns-Correlation Study with Contrast-enhanced CT

    Radiology:Volume 260: Number 1 -July 2011

    Xiang Zhou, MD Yan Luo, MD Yu-Lan Peng, MD Wei Cai, MD Qiang Lu, MD Ling Lin, MD Xiao-Xi Sha, MD Yong-Zhong Li, MD Meng Zhu, MD

    Purpose: To retrospectively compare the detection and character­ization of hepatic perfusion disorder (HPD) associated with focal liver lesions (FLLs) at contrast material-enhanced ul­trasonography (US) by using contrast-enhanced computed tomography (CT) as the reference standard.

    Materials and Methods: The study was approved by the local institutional ethics com­mittee, and informed consent was waived. Three hundred fifty patients (mean age, 50 years ± 11 [standard deviation]; age range, 19-82 years; 168 women, 182 men) under­went contrast-enhanced US and contrast-enhanced CT be­tween April 2008 and July 2010. Two independent readers reviewed contrast-enhanced US images for the detection and characterization of HPD. The largest lesion or the le­sion best identified at contrast-enhanced US per patient was used for statistical analysis. Contrast-enhanced CT was used as the reference standard. Contrast-enhanced US and CT interreader agreement of diagnoses was assessed by using the weighted k coefficient, and influences of le­sion size, enhancement covering rate, and liver cirrhosis were evaluated by using logistic regression analysis and the paired x2 test. Sensitivity, specificity, positive and neg­ative predictive values, and accuracy of contrast-enhanced US for HPD detection were calculated.

    Results: Contrast-enhanced US results showed HPD features similar to those of CT imaging. CT depicted 50 HPDs in 350 pa­tients, and contrast-enhanced US depicted 55 HPDs in 350 patients. The agreement for HPD diagnosis between US and CT was good (k = 0.749). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of contrast-enhanced US were 84.0%, 95.7%, 76.4%, 97.3%, and 0.945, respectively. Rapid enhancement coverage (P < .001) and lesion size (P = .002) were significant predictors of the occurrence of HPD. Liver cirrhosis did not have signifi­cant influence for HPD detection (P = .087). Image zooming, limited acoustic window, lesion diameter greater than 5 cm, attenuation, and blurred images were the main reasons for the false-positive diagnosis of HPD at contrast-enhanced US.

    Conclusion: The HPD in FLLs can reliably be detected with contrast-enhanced US, which correlated well with contrast-enhanced CT images.